BCM
Boxer Capital Management Portfolio holdings
AUM
$199M
This Quarter Return
-6.27%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$332M
AUM Growth
+$332M
(-72%)
Cap. Flow
-$739M
Cap. Flow
% of AUM
-222.23%
Top 10 Holdings %
Top 10 Hldgs %
72.35%
Holding
62
New
2
Increased
2
Reduced
10
Closed
34
Top Buys
| 1 |
Solid Biosciences
SLDB
|
$4.59M |
| 2 |
Denali Therapeutics
DNLI
|
$3.4M |
| 3 |
Prelude Therapeutics
PRLD
|
$308K |
| 4 |
Kodiak Sciences
KOD
|
$98.4K |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$124M |
| 2 |
Revolution Medicines
RVMD
|
$105M |
| 3 |
Merus
MRUS
|
$50.5M |
| 4 |
Nuvalent
NUVL
|
$47.5M |
| 5 |
Axsome Therapeutics
AXSM
|
$39.8M |
Sector Composition
| 1 | Healthcare | 99.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sana Biotechnology
SANA
$777M
| – | – | -1,545,000 | Closed | -$2.52M |
|
52
Summit Therapeutics
SMMT
$17.6B
| – | – | -250,000 | Closed | -$4.46M |
|
53
Scholar Rock
SRRK
$3.14B
| – | – | -750,000 | Closed | -$32.4M |
|
|
SWTX
54
DELISTED
SpringWorks Therapeutics
SWTX
| – | – | -3,421,541 | Closed | -$124M |
|
55
Spyre Therapeutics
SYRE
$996M
| – | – | -466,680 | Closed | -$10.9M |
|
56
Terns Pharmaceuticals
TERN
$609M
| – | – | -752,000 | Closed | -$4.17M |
|
|
THRD
57
DELISTED
Third Harmonic Bio
THRD
| – | – | -2,000,000 | Closed | -$20.6M |
|
58
Tyra Biosciences
TYRA
$675M
| – | – | -2,027,678 | Closed | -$28.2M |
|
59
Zentalis Pharmaceuticals
ZNTL
$122M
| – | – | -450,000 | Closed | -$1.36M |
|
60
Zura Bio
ZURA
$133M
| – | – | -300,000 | Closed | -$750K |
|
|
BCAX
61
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
| – | – | -135,000 | Closed | -$2.35M |
|
|
PSTX
62
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| – | – | -2,000,000 | Closed | -$19.2M |
|